Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Sterility Testing of Injectable Products – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Sterility Testing of Injectable Products – V 2.0

Standard Operating Procedure for Sterility Testing of Injectable Products


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/061/2025
Supersedes SOP/SIM/061/2022
Page No. Page 1 of 15
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP outlines the method for conducting sterility testing of injectable products to detect the presence of viable microorganisms in sterile pharmaceutical preparations using validated test procedures as per pharmacopoeial standards.

2. Scope

This SOP is applicable to all final sterile injectable

drug products manufactured in-house and intended for release after sterility testing at [Company Name] microbiology laboratory.

3. Responsibilities

  • Microbiology Analyst: Performs sterility testing following aseptic techniques and documents the observations.
  • Quality Control Manager: Reviews and approves sterility test records and results.
  • Quality Assurance: Ensures compliance with regulatory requirements and reviews final reports.
See also  Formulation Development: SOP for Risk Management in Product Development Lifecycle - V 2.0

4. Accountability

Head – Quality Control shall be accountable for execution and compliance of the sterility testing process.

5. Procedure

5.1 Pre-Test Preparations

  1. Verify cleanliness and calibration status of the sterility test isolator or laminar air flow workbench.
  2. Check environmental monitoring results prior to test initiation.
  3. Ensure media (FTM and SCDM) are clear, not expired, and pass growth promotion tests.
  4. Label test containers with sample code and media type.

5.2 Sampling and Media

  • Use Fluid Thioglycollate Medium (FTM) for anaerobic and aerobic bacteria.
  • Use Soybean Casein Digest Medium (SCDM) for fungi and aerobic bacteria.
  • Samples shall be tested within 24 hours of sampling. If delayed, store at 2–8°C (not exceeding 72 hours).

5.3 Sterility Test Methods

5.3.1 Membrane Filtration Method (Preferred)

  1. Assemble sterile filtration apparatus and membrane units inside isolator/LAF under Grade A conditions.
  2. Filter product through 0.45 µm or finer filter.
  3. Rinse filters with sterile fluid (minimum three rinses of 100 mL).
  4. Transfer one filter to FTM and another to SCDM.
  5. Incubate FTM at 30–35°C and SCDM at 20–25°C for 14 days.
See also  Sterile Injectable Manufacturing: SOP for Filtration Process in Sterile Injections - V 2.0

5.3.2 Direct Inoculation Method (If Filtration Not Feasible)

  1. Inoculate a measured quantity of the product directly into FTM and SCDM media.
  2. Observe for signs of turbidity or microbial growth over 14 days.

5.4 Controls and Monitoring

  • Include negative controls with media only (no product) in every run.
  • Perform growth promotion test on positive control organisms (B. subtilis, C. albicans, etc.) periodically.
  • Document incubator temperature, media lot, test environment, and analyst details.

5.5 Observation and Results

  1. Visually inspect test media daily for turbidity or sediment formation.
  2. Record observations in the Sterility Test Log (Annexure-1).
  3. If microbial growth is observed, isolate, identify the organism, and initiate an OOS investigation.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • FTM: Fluid Thioglycollate Medium
  • SCDM: Soybean Casein Digest Medium
  • OOS: Out of Specification
  • LAF: Laminar Air Flow

7. Documents

  1. Sterility Test Log – Annexure-1
  2. Growth Promotion Test Records – Annexure-2
  3. Sterility Test Report Format – Annexure-3
See also  Sterile Injectable Manufacturing: SOP for Particulate Matter Testing in Sterile Injections - V 2.0

8. References

  • USP <71> Sterility Tests
  • EP 2.6.1 Sterility
  • WHO TRS 1010, Annex 6

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Analyst QC Manager Head QA
Department Quality Control Quality Control Quality Assurance

11. Annexures

Annexure-1: Sterility Test Log

Date Batch No. Product Name Media Used Observation Analyst
17/06/2025 IVINJ0234 Inj. Ceftriaxone FTM/SCDM No Growth Neha Verma

Annexure-2: Growth Promotion Test Record

Media Organism Inoculum Result Date Analyst
FTM B. subtilis 100 CFU Growth 16/06/2025 Sagar Patil

Annexure-3: Sterility Test Report

Product Batch Test Date Result Reviewed By
Inj. Pantoprazole IVPNT045 15/06/2025 Complies Dr. Sheetal Nair

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
18/06/2025 2.0 Updated with detailed filtration and inoculation steps Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Biosimilars: SOP for Tracking Consumables in Bioreactor Runs – V 2.0
Next Post: Gel Manufacturing: SOP for Investigating Gel Batch Failures – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version